Type 2 deiodinase (D2) is a selenoenzyme catalyzing the activation of T 4 to T 3 . D2 activity/mRNA ratios are often low, suggesting that there is significant posttranscriptional regulation. The D2 mRNA in higher vertebrates is more than 6 kb, containing long 5 and 3 untranslated regions (UTRs). The D2 5UTRs are greater than 600 nucleotides and contain 3-5 short open reading frames. These full-length 5UTRs reduce the D2 translation efficiency approximately 5-fold. The inhibition by human D2 5UTR is localized to a region containing the first short open reading frame encoding a tripeptide-MKG. This inhibition was abolished by mutating the AUG start codon and weakened by modification of the essential purine of the Kozak consensus. Deletion of the 3.7-kb 3UTR of the chicken D2 mRNA increased D2 activity approximately 3.8-fold due to an increase in D2 mRNA half-life. In addition, alternatively spliced D2 mRNA transcripts similar in size to the major 6-to 7-kb D2 mRNAs but not encoding an active enzyme are present in both human and chicken tissues. T YPE 2 DEIODINASE (D2) catalyzes the 5Ј monodeiodination of T 4 to T 3 , the first step found in the process by which T 4 produces its effects. It is widely expressed in humans being in brain, pituitary, brown adipose tissue, placenta, skeletal, and cardiac muscle and skin (1, 2). Because D2 contains the rare amino acid selenocysteine encoded by UGA in its active center, its successful translation requires specific sequences, the selenocysteine insertion sequence (SECIS) element, in its 3Ј untranslated region (UTR) (3). Even so, its translational efficiency, like that of other selenoproteins, is much less than that of typical proteins (4). The process can also be influenced by selenium and by the components of the selenocysteine insertion machinery (5-7).
T YPE 2 DEIODINASE (D2) catalyzes the 5Ј monodeiodination of T 4 to T 3 , the first step found in the process by which T 4 produces its effects. It is widely expressed in humans being in brain, pituitary, brown adipose tissue, placenta, skeletal, and cardiac muscle and skin (1, 2) . Because D2 contains the rare amino acid selenocysteine encoded by UGA in its active center, its successful translation requires specific sequences, the selenocysteine insertion sequence (SECIS) element, in its 3Ј untranslated region (UTR) (3) . Even so, its translational efficiency, like that of other selenoproteins, is much less than that of typical proteins (4) . The process can also be influenced by selenium and by the components of the selenocysteine insertion machinery (5-7).
Interestingly, D2 activity/mRNA ratios show marked variations. In tissues such as the normal human thyroid, D2 activity is lower than would be expected from the amount of D2 mRNA expressed. For example, in the thyroid tissue of a Graves' patient, the D2 activity/ mRNA ratio was 25-fold that in normal human thyroid (8, 9) . In human thyroid adenomas, the D2 activity/ mRNA ratio is also higher than in normal thyroid, indicating that there are variations in posttranslational processing (10).
It is not understood which components of the highly complex D2 regulation might be involved in the generation of these variations in mRNA/activity ratios between tissues. The dio2 (type 2 iodothyronine deiodinase) gene has multiple transcription start sites (TSSs) , and the transcriptional regulatory component involves cAMP, thyroid transcription factor-1, T 3 , and activator protein-1 regulated pathways (11) (12) (13) (14) (15) . In addition, T 4 or 3,3Ј5Ј triiodothyronine (reverse T 3, r T 3 ) cause significant posttranslational down-regulation. The latter effect involves substrate-accelerated selective proteolysis via the ubiquitin/26 S proteasome pathway (16) (17) (18) .
The D2 mRNAs of vertebrates are unusually long (ϳ6-7 kb) compared with the 2-to 2.5-kb length of the other two members of the selenodeiodinase family. Despite this large size, the open reading frame (ORF) encoding the active enzyme is only approximately 800 bp. The 3ЈUTR is extremely long (Ͼϳ4.7 kb) and contains a SECIS element at its 3Ј end. This is the greatest distance yet recognized between a SECIS element and the UGA codon and could theoretically attenuate successful readthrough of the two UGA codons in the mRNA (19) (20) (21) . The 5ЈUTR of the D2 mRNAs is at least approximately 600-bp long and the mRNAs of the four species cloned all contain 3-5 short ORFs (sORF), which may also modulate translation. The goal of our study was to elucidate the role of mRNA structure in the posttranscriptional regulation of this key ratelimiting gene in thyroid hormone activation.
RESULTS

The Translation of D2 mRNA Is Regulated by Its 5UTR
Comparison of the 600-to 700-bp 5ЈUTR of the dio2 genes of higher vertebrates shows a number of common features. The human D2 (hD2) 5ЈUTR has 73, 70, and 46% identity to the rat, mouse, and chicken sequences, respectively. Virtual identity exists in the most 5Ј approximately 20 bases, which form putative stem loop structures by GCG FOLDRNA analysis (Fig.  1A) . The more 3Ј portions of these 5ЈUTR contain 3-5 putative sORFs (Fig. 1B) . The sORFs were defined considering the unique feature of selenoprotein mRNAs in which SECIS elements in the 3ЈUTR suppress the stop codon function of UGA codons. Unambiguous stop codons (UAA and UAG) and in-frame UGA codons followed by purines were considered as translational terminators, whereas in-frame UGAs followed by pyrimidines favor readthrough and are indicated by an asterisk (22) . The deduced peptide sequences of these ORFs have low similarity between species with the exception of rat and mouse (Fig. 1B) .
We developed a chicken D2 (cD2)-containing reporter system to explore the potential role of these 5ЈUTR sequences in modulating the translation efficiency of this selenoprotein. The human and chicken cD2 5ЈUTR caused a 5-fold reduction in transient cD2 expression in HEK-293 cells (Fig. 2) . This was not due to the conserved sequences in the 5Ј region (Fig. 1A ) because deletion of these had no effect. The 5ЈUTR of cD2 was as effective as that of the human mRNA in decreasing D2 activity. Northern blots showed no inhibitory effect of the sORFs on the transient expression of the cD2 mRNA (data not shown). In fact, the D2/actin mRNA/human GH (hGH) ratio of full-length cD2 was about 3-fold higher than that of the ⌬5ЈUTRcD2 construct, whereas the activity in the same experiments was 2-to 3-fold lower. The effect on D2 activity of 5ЈUTR fragments containing the hORF-A was not different from that of the hD2-5ЈUT⌬ containing the sORFs. However, constructs lacking the sORF-A were significantly less effective in sup-
Fig. 1. Alignment of D2 5ЈUTR Portions
A, Alignment of the 5Ј portion of the human, chicken, rat, and mouse D2 mRNAs. The region just 3Ј to the transcription start site is highly conserved. Alignments were performed by GCG PILEUP. B, Deduced amino acid sequences of the putative amino acid sequence of the sORFs in the human, chicken, rat, and mouse D2 5ЈUTR. Unambiguous stop codons and in frame UGAs followed by purines were considered as translational terminators. In-frame UGAs in possible readthrough position (codon followed by a pyrimidine) are indicated by an asterisk (22) . The presence of a strong translational initiation sequence (Ϫ3 purine where position 1 is the A of the start codon) is indicated by a plus sign (39) .
pressing D2 activity than those containing sORF-B or C (Fig. 3) . Thus, the sORF-A encoding the tripeptide MKG was the predominant translation inhibitory region in the hD2 5ЈUTR.
Mutagenesis was used to inactivate the AUG codon of the human sORF-A and the shortest chicken ORF-B to determine the structure-activity relationships (Fig. 1B) . Replacement of ATG by TTG completely abolished the inhibitory effect of the sORFs on D2 translation (Fig. 4) . The suppressive activity of human sORF-A was also decreased by changing the Kozak consensus replacing the Ϫ3A with C. These data in- The hD2 5ЈUTR fragments were inserted into the cD2 reporter (see Fig. 2 ) and transiently transfected into HEK-293 cells as described in Materials and Methods. Data are the mean Ϯ SEM of the relative D2 activities of duplicate plates in at least three separate experiments as a percent of the cD2 reporter control. *, P Ͻ 0.05; **, P Ͻ 0.01 vs. hD2-5ЈUT⌬ by ANOVA followed by Newman-Keuls.
Fig. 2. Effect of the Human and Chicken 5ЈUTR on D2 Expression
The hD2 or cD2 5ЈUTR were inserted between SacII and EcorI of the cD2 reporter containing the cD2 coding region followed by the rat D1 minimal SECIS element. Plasmids were transiently transfected into HEK-293 cells as described in Materials and Methods. Data are the mean Ϯ SEM of relative D2 activities of duplicate plates in at least three separate experiments as a percentage of the activity of the cD2 reporter. All results are corrected for transfection efficiency. *, P Ͻ 0.001 vs. cD2 by ANOVA followed by Newman-Keuls.
dicate that translational initiation of the sORF is required to decrease the translation of the 3Ј major coding cistron. The hORF-A(Wt)-cD2 and hORF-A(Mut-ATG)-cD2 were also transfected into GH4C1 and Met5A (which express endogenous D2) and COS-7 and JEG cells (no endogenous D2) to analyze for possible cell type specific effects. In all cell lines tested, the relative D2 activity (calculated as percentage of the cD2 reporter) produced by the hORF-A(Wt)-cD2 was significantly lower than that of produced by hORF-A(Mut-ATG)-cD2 constructs (Table 1 ). This indicates that the sORF based translational inhibition of D2 activity is not restricted to cell types not expressing endogenous D2.
Wild-type (wt) or mutant (mut) ATG-containing sORF-A containing cDNAs were also inserted in separate eukaryotic expression plasmids and cotransfected with the cD2 reporter. The cotransfection of the wt, MKG or mut LKG, encoding expression plasmids did not affect cD2 expression from the cD2 plasmid, indicating neither the peptide nor the ORF-A mRNA is inhibitory (not shown). When the wt or TTG-containing human sORF-A was inserted 5Ј to the rat D1 coding sequence, the wt sORF-A, but not the mut, suppressed D1 activity, indicating that the suppressive effect of this sORF is not D2 specific (Fig. 5) .
The D2 3UTR Affects the D2 mRNA Half-Life and Translation Efficacy
The 3ЈUTR of the vertebrate D2 mRNAs is at least 4.7 kb, and each contains the required SECIS element at its 3Ј terminus (19) (20) (21) . The human, chicken, and mouse D2 3ЈUTR (GenBank accession no. AF096875) also contain 11, 9, and 7 AUUUA putative mRNA instability motifs, respectively. These sequences are surrounded by adenine/uracil (A/U) rich regions as is characteristic of instability motifs (19, 21, 23) .
The cD2 3ЈUTR was restricted to remove 3710 nucleotides (nt) containing 8 of the 9 AUUUA motifs between the coding region and the SECIS element (cD2-3.7⌬, in Fig. 6A ). To keep the distance constant between the active center and the SECIS element, exogenous DNA from Neurospora crassa or from the mouse thyroid receptor ␣, without AUUUA motifs, was inserted (cD2-3.7exo). Replacement of the 3ЈUTR increased D2 activity by approximately 50%, whereas elimination of the 3ЈUTR increased D2 activity approximately 3.8-fold relative to the cD2wt (Fig. 6A) . Transfections were performed with 1, as opposed to 10, g D2-expression plasmid with the same result, indicating that the selenoprotein synthesis was not saturated.
The D2 mRNA was quantified by Northern blots in two separate experiments using a coding region probe. The mRNA of the cD2-3.7exo and cD2-3.7⌬ were 0.6-and 4-fold that of cells transfected with cD2wt, respectively (data not shown). Mutagenized nucleotides are shown in bold and underlined. Fragments were inserted into the cD2 reporter (see Fig. 2 ) and transiently transfected into HEK-293 cells as described in Materials and Methods. Data are the mean Ϯ SEM of relative D2 activities of duplicate plates in at least three separate experiments. *, P Ͻ 0.05; **, P Ͻ 0.001 vs. hORF-A(Wt)-cD2 by ANOVA followed by Newman-Keuls. ***, P Ͻ 0.05 vs. cORF-B(Wt)-cD2 by unpaired t test. To evaluate possible differences in mRNA stability, similarly transfected cells were exposed to tetracycline to stop transcription from the tetracycline-repressible promoter (see Materials and Methods). After 13 h of tetracycline exposure, the amount of cD2-3.7exo mRNA was approximately 2.5-fold higher than in the cells transfected with the cD2wt (Fig. 6B ). This suggested that elimination of the 8 AUUUAs contained in the 3ЈUTR increased the mRNA half-life.
As is apparent in Fig. 6B , deletion of most of the 3ЈUT (cD2-3.7⌬) leads to the presence of large quantities of two D2 transcripts. The larger transcript is of the expected size (approximately 2.1 kb). The blot was reprobed using a cD2 SECIS region probe, and the same doublet was observed indicating that both mRNAs are potentially functional. The densities of the bands were 15-fold (larger) and 40-fold higher than the wt, respectively.
Cloning and Functional Testing of Alternatively Spliced D2 Coding Region Transcripts in Chicken and Human Tissues
Despite similar D2 mRNA levels in the telencephalon and liver of the adult chicken (21), the maximum velocity for D2 is 2.6-fold higher in brain tissue (408 vs. 156 fmol T 4 /h⅐mg protein). While only a single 6.1-kb D2 was observed in both tissues, a potential explanation for this discrepancy is the presence of a second mRNA in liver similar in size but not encoding an active protein. This proved to be the case with cDNAs cloned from two animals demonstrating a 77-bp deletion just 5Ј to the region corresponding to the exon/intron junction in the human D2 coding region (Fig. 7A ). The absence of these nucleotides resets the reading frame and the deduced amino acid sequence of the ⌬77cD2 protein is terminated short of the active center (Fig.   7B ). The coexistence of the normal and ⌬77cD2 mRNA was shown in the telencephalon and liver by PCR (Fig. 7C ). As predicted, the ⌬77cD2 mRNA did not encode an active D2 in transiently transfected HEK-293 cells.
Alternatively spliced human D2 mRNAs involving the same intron/exon junction were also found in human thyroid tissue samples (see Materials and Methods). Three samples had two transcripts (see Fig. 8A ). The cDNAs of the three abnormal (longer) transcripts were cloned and sequenced. All had an identical 108-bp in-frame insertion that also contained an in frame TGA followed by a C, a context that can support UGA translation (Fig. 8B) . To see if this mRNA could encode a functional D2, the hD2ϩ108 coding region was placed 5Ј to a SelP SECIS element with a FLAG epitope fused to the NH2 terminus. The protein was transiently expressed in HEK-293 cells in Na 2 ( 75 Se)O 3 containing media and immunoprecipitated by anti-FLAG antibody. Autoradiography showed that the hD2ϩ108 coding region encoded a protein of approximately 35 kDa (Fig. 8C) . This corresponds to the calculated size based on the deduced amino acid sequence of the putative full-length D2ϩ108 protein indicating that the UGA is translated. No band of this size was visible in the control lane. The hD2ϩ108 transfected HEK-293 cell sonicates contained no D2 activity. Sequence analysis showed that the 108 bp is derived from the midportion of the approximately 8-kb intron separating hdio2 exon ␣ and ␤ (Fig. 8D ).
DISCUSSION
Our results document several previously unrecognized characteristics common to the D2 mRNAs of four dif- The fragments were inserted into a rD1 reporter element and the plasmid transiently transfected into HEK-293 cells as described in Materials and Methods. The mutagenized nucleotide is shown in bold and underlined. Data are the mean Ϯ SEM of relative D1 activities of duplicate plates in at least three separate experiments as percent of the rD1 reporter control. *, P Ͻ 0.05 vs hORF-A(Wt)-rD1 by unpaired t test. ferent species which can explain discrepancies between D2 mRNA content and D2 activity in different tissues. Quantitatively most important is the effect of the 5ЈUTR, which causes a 5-fold reduction in D2 expression in HEK-293 cells (Fig. 2) . While there are 3-5 sORFs in the 5ЈUTRs of the human, chicken, rat, and mouse D2 mRNAs (Fig. 1B) , in the human D2 it is the most 5Ј sORF (hORF-A), which is primarily responsible for this effect (Fig. 3) . These sORFs encode a tri-(human, rat, mouse) or di-peptide (chicken). The hORF-A operates only in cis and requires an AUG codon. All of the shortest D2 5ЈUT ORFs have Kozak consensus sequences with purines at Ϫ3 and ϩ4 relative to the ATG, and an A to C substitution at Ϫ3 of the hORF-A reduces the translational inhibition by about 2-fold (Fig. 4) . The inhibitory effect was not D2-specific (Fig. 5) . Our results suggest there is no tissue specificity to the inhibitory function of hORF-A ( Table 1) .
The best characterized examples of sORF-based translational regulation occur in yeast and viruses. The translation of the yeast GCN4 transcription factor is increased by amino acid starvation. This process is regulated by the 4 sORFs in the 5ЈUTR in a manner independent of the amino acid sequence of the putative peptides. The phosphorylation state of eIF-2 controls the re-initiation frequency at ORF4 (see Ref. 24 for review). In contrast, the yeast CP1 leader expresses a 25 amino acid leader peptide that suppresses the translation of the glutaminase subunit of the carbamoyl-phosphate synthetase in a sequence-specific manner (25) . Another well-documented mechanism for bypassing sORFs occurs in Picornaviruses where specific cis acting RNA sequences, the internal ribosome entry segment, allow translation of major 3ЈORFs (26) . On the other hand, the Cauliflower mosaic virus 35S RNA utilizes nonlinear ribosome migration, ribosome shunting, to bypass the inhibitory sORFs (for review see Ref. 27 ). 6 . Effect of the cD2 3ЈUTR on mRNA Levels and D2 Activity A, Expression constructs containing cD2 with intact (cD2wt), replaced (cD2-3.7exo) or deleted (cD2-3.7⌬) 3ЈUTR were prepared. A non-AUUUA containing fragment of 3.7 kb originating from the Pho2 gene of Neurospora crassa and the mouse TR␣ was inserted into the cDNA (see Materials and Methods) and transiently transfected into HEK-293 cells. D2 activity was measured in duplicate HEK-293 plates transfected with cD2wt, cD2-3.7exo and cD2-3.7⌬ constructs in at least three separate experiments. Data are the mean Ϯ SEM % D2 activity normalized for transfection efficiency for hGH (cpm/100 l media). *, P Ͻ 0.01 vs. cD2wt by ANOVA followed by Newman-Keuls. B, The amount of D2 mRNA quantitated by Northern blotting in two separate experiments 13 h after inhibition of transcription using 1 g/ml tetracycline as described in Materials and Methods. Both of the doublet bands in cD2-3.7⌬ transfected cells hybridized with both cD2 coding-and SECIS-containing sequences.
The translational mechanism for higher vertebrates containing a 5ЈUTR with sORFs upstream of the major coding sequence is poorly understood. Only 10% of 5ЈUTR vertebrate mRNAs contain such sequences (28) . This group of genes includes transcription and growth factors, proto-oncogenes, receptors of the G protein-coupled receptor superfamily, and signal transduction components (29) . Examples include Angiotensin II type IA receptor (30) , CCAAT/enhancerbinding (31), ornithine decarboxylase (32), fibroblast growth factor-5 (33), the alcohol dehydrogenase-5/ formaldehyde dehydrogenase and Myf6 genes (34), serine hydroxymethyltransferase (35), the HER-2 receptor (36) , and the ␤2 adrenergic receptor (37) . The human ␤2 adrenergic receptor 5ЈUTR contains an sORF encoding a 19-amino acid peptide that inhibits the translation of the protein. As in the case of D2 mRNA, the effect is not specific to the homologous coding sequence and it functions only in cis. Similar to human D2, a CTT for ATG substitution in the sORF increases the receptor protein translation approximately 2-fold. There is a single nucleotide polymorphism in this mRNA altering amino acid 19 from ARG to CYS. This leads to a 2-fold increase in the translation efficiency of the receptor in a cell-line endogenously expressing the protein indicating that the suppressive effect of the ORF is influenced by the peptide (38) . The number and sequence of the sORFs in the D2 5ЈUTRs are not conserved between species, not even between the most potent sORF-A, indicating that the suppressive effect is independent of peptide sequence but common to all D2 mRNAs. Interestingly, the human D2 sORF-B also has a Ϫ3 purine (G), but this sORF does not suppress D2 translation (Figs. 1B  and 3 ). This, taken together with the successful initiation from the weak translation initiation sequence of the ␤2 adrenergic receptor sORF, suggests in accordance with the findings of Kozak (39) that other factors, such as secondary structure, should be taken into consideration when assessing the translational inhibitory potential of a 5ЈUT sORF. The 5Ј terminal end of the D2 5ЈUTRs have high sequence similarity (Fig. 1A) and computer-assisted methods predict secondary structures for this region. However, we found no suppressive effect of this portion of the human D2 5ЈUTR on D2 translation.
It is not yet clear whether the translational suppression caused by the D2 5ЈUTR is constitutive or inducible. Within a given cell type or tissue, increases in D2 mRNA, such as those induced by adrenergic mechanisms in pineal gland or during development, increase D2 activity more or less in parallel (40) (41) (42) . However, recent analyses of D2 activities in hyperfunctioning human thyroid adenomas show that the ratios between adenoma and normal are greater for D2 activity (approximately 5-fold) than for D2 mRNA (approximately 3-fold), suggesting there may be more efficient translation as well as increased mRNA as an explanation for increased D2 (10) . Further studies will be required to explore these possibilities.
The long 3ЈUTR of the D2 mRNA has many AUUUA instability motifs and the D2 mRNA has an approximately 2-h half-life (14, 19, 21) . The study of the functional role of these structures is complicated by the fact that reducing the length of the 3ЈUTR simultaneously alters the relative proximity of the SECIS element to the UGA in the catalytic center of the coding region. Increasing the distance between the SECIS element and the coding region of the rat type 1 deiodinase by 1.5 kb does not decrease D1 expression (43) . However, the larger change of 3.7 kb could have such effects. Substitution of Neurospora and mouse thyroid receptor ␣ DNA, which have no AUUUA elements, for the chicken D2 3ЈUT cause a 50% increase in transient D2 expression (Fig. 6A) . However, the amount of D2 mRNA 13 h after inhibition of D2 transcription was 2.5-fold higher (Fig. 6A) . Because both the cD2wt, cD2-3.7exo, and cD2-3.7⌬ mRNAs were expressed using the same promoter contained in the same nucleotide context, this finding suggests that the half-life of the chimeric mRNA was prolonged. Deletion of the 3.7-kb fragment increases D2 activity 3.5-fold, but there is a much greater increase in the mRNA after blocking transcription, again suggesting that the truncated mRNA is more stable.
Even though the structures of the transcripts in cD2-3.7⌬ transfected cells are not defined (Fig. 6B) , both the shorter and longer mRNAs hybridize with both coding sequence and the SECIS element containing probes indicating that both can potentially be translated. The differences in D2 expression are not changed by a 10-fold reduction in transfected plasmid making it highly unlikely that saturation of one or more of the components required for selenoprotein synthesis limits translation. Thus, we are unable to address definitively the role of the 3ЈUTR in D2 translation efficiency.
Alternative Splicing in the Coding Region of the D2 mRNA Gives Rise to Inactive D2 Proteins
At least three 6-to 7-kb D2 mRNA transcripts differing by 500-700 nt have been identified in human thyroid, and two in brain and other tissues (1, 9, 11). However, differences of 50-100 nt are impossible to recognize by size alone in such a long mRNA. We have identified two D2 transcripts in chicken brain and liver, one of which encodes an inactive protein. The cDNA encoding the inactive D2 lacks 77 nt in the coding region, apparently due to the use of an alternative splice site. The genomic organization of the cdio2 gene is not known but the 3Ј end of the missing cD2 77 bps maps exactly to the position of the exon/intron junction of the mouse and human dio2 genes, suggesting the alternative processing of an intron in the same position (Fig. 7A) (11, 20, 44) . PCR studies show that both wt and ⌬77cD2 transcripts are expressed in both telencephalon and liver and different ratios could account for different D2 activity/mRNA ratios.
Fig. 7. Sequence and Expression of the ⌬77cD2 Transcript
A, Alignment of the coding region of the chicken and human D2 coding regions (GenBank accession nos. AF125575 and U53506, respectively) to the sequence of the cD2. Seventy-seven base pairs (underlined) are missing from the cD2-clone no. 2. 5Ј and 3Ј nucleotides of the spliced region are indicated in bold. A polymorphism of cD2-clone no. 1 is shown in italics. The insertion site of the hdio2 intron is marked by an arrow. B, Nucleic acid and deduced amino acid sequences of the alternatively spliced cD2 mRNA. The wt cD2 amino acid sequence is underlined and bold, the new junction is underlined and shown in bold italics. Numbers show positions in the cD2 mRNA GenBank accession no. AF125575. C, Agarose gel electrophoresis of the PCR products from wt cD2 mRNA from telencephalon (T) and liver (L) from an adult chicken using Bp3 and Bp90 oligos (sequences are indicated in Table 2 ). The expected 277-bp band and a second approximately 200-bp product were generated. The products Similarly, an alternatively spliced hD2 mRNA encoding an inactive protein is expressed in human thyroid tissue. This transcript is readily seen on RT-PCR using oligonucleotides spanning the exon-intron junction between the two coding exons ␣ and ␤ (Fig. 8, A and  D) . It derives from an alternative 5Ј exon-intron junction leading to insertion of 108 intronic nucleotides after codon 74 (Fig. 8, B and D) . The insertion does not change the reading frame and is translated even though it contains an additional UGA codon (Fig. 8, B and C). It has no catalytic activity. Parallel with the cloning of the thyroidal hD2ϩ108 coding region described here an hDII-b splice variant of the same sequence (GenBank accession no. AB041843) was cloned from a human umbilical vein endothelial cell line ECV304 by Ohba et al. (45) . They also demonstrated the presence of the hDII-b transcript by RT-PCR in the human brain, lung, kidney, heart, and trachea. Another hD2 mRNA with a 242-bp-long genomic insertion (hDII-c) has also been cloned from ECV304 cells (GenBank accession no. AB041844) (45). We could not detect this transcript in human thyroid by RT-PCR.
Two other D2 mRNA variants have been cloned. In a mouse cochlear cDNA library, a clone was identified containing a truncated D2 coding region followed by the 3ЈUTR (GenBank AF177197) (42) . Interestingly, in this case the divergence point was 35 bp 3Ј to the conserved exon/intron junction. The transcript abundance and its functional properties were not reported. The hD2 5ЈUTR contains an alternatively spliced intron in human thyroid (11) . The last four nucleotides of hORF-B and the whole region encoding hORF-C are missing from this D2 mRNA but the potent hORF-A is not affected.
In summary, a number of posttranslational mechanisms can regulate the D2 content of a given tissue. Selenium deficiency reduces D2 activity approximately 30-fold in the mesothelioma cell line MSTO-211 (6). Substrate-induced acceleration of D2 ubiquitination leads to rapid proteasomal degradation, reducing the D2 protein half-life 2-to 3-fold (18) . The present studies show that sORFs in the 5ЈUTR reduce D2 expression by as much as 5-fold. Alternative splicing is another mechanism that dictates the D2 concentration in specific tissues, such as the brain, liver, and thyroid of chickens or humans. While the long, approximately 5-kb 3ЈUT separating the UGA in the D2 active center from the SECIS element might have been expected to reduce the D2 activity/mRNA ratio by reducing translation, our studies suggest that the AUUUA instability motifs and, more importantly, reducing the distance between the SECIS and coding region may decrease D2 expression by destabilizing the D2 mRNA. However, more direct studies of translational efficiency will be required to confirm this.
The multiplicity of potential regulatory mechanisms for this protein argues that there is meticulous control of the deiodinative activation of T 4 to T 3 . The demonstration that much of this occurs at a posttranscriptional level indicates that D2 activity in different tissues cannot be inferred simply by quantitating its mRNA.
MATERIALS AND METHODS
DNA Transfection
Cells were transfected as previously described using calcium phosphate precipitation (46) . GH4C1 cells were transfected using Lipofectamine Plus (Life Technologies, Inc., Gaithersburg, MD). Ten micrograms of pUHD10-3 based vector encoding the deiodinase was transiently transfected together with 4 g pUHD-15, which is required for the transcriptional activation of the pUHD10-3 promoter. This activation can be suppressed by tetracycline that inhibits the binding of the activator expressed by pUHD-15 to the pUHD10-3 promoter (47). The transfection efficiency was monitored by the cotransfection of 3 g TKGH and hGH was assayed in the media and used to correct D2 or D1 activities (48) . Results are given as the mean Ϯ SEM of D2 or D1 activities of duplicate plates of at least three separate experiments as the percentage of the cD2 or rD1 control, respectively.
Expression Constructs
The cD2 reporter construct contained a 33-bp cD2 5ЈUTR fragment as spacer between the cloning site and the initiator ATG followed by the cD2 coding region between EcorI-HindIII and a rD1 minimal SECIS element between HindIII-NotI (21). In the constructs described below, different UTR fragments were cloned between the SacII site of the D10 vector and RI if not indicated otherwise. The human 5ЈUTR Vent PCR fragments were generated from the hdio2 clone 2 (11) . The name of the construct is followed by the oligos in parentheses used to prepare it: hdio2-5ЈUT (Bp35-Bp37); hdio2-5ЈUT⌬ (Bp36-Bp37); hORF-A,B-cD2 (Bp36-Bp38); hORF-A-cD2 (SacIIApoI fragment of the Bp36-Bp38 PCR); hORF-B-cD2 (ApoIEcoRI fragment of the Bp36-Bp38 PCR with the ApoI at 5Ј); hORF-C-cD2 (Bp39-Bp37); hdio2-5ЈUT(41/240)-cD2 (Bp36-Bp60); hORF-A(Wt)-cD2 (Bp52 was ligated to the corresponding antisense, latter was not indicated in Table 2 ); hORF-A(Mut-ATG)-cD2 (Bp54 and corresponding antisense); hORF-A(Mut-Koz)-cD2 (Bp62 and corresponding antisense); cORF-B(Wt)-cD2 (Bp68 and corresponding antisense); cORF-B(Mut-ATG)-cD2 (Bp70 and corresponding antisense).
The hORF-A(Wt)-cD2 and hORF-A(Mut-ATG)-cD2 were cut by EcorI-NotI and religated, generating in this way hORF-A(Wt)-D10 and hORF-A(Mut-ATG)-D10, respectively. As the rD1 reporter a construct containing a rD1 coding sequence followed by rat D1 minimal SECIS element was used (49) . The hORF-A(Wt)-cD2 and hORF-A(Mut-ATG)-cD2 were cut by EcorI-HindIII and the EcorI-HindIII fragment of the rD1 reporter (the rD1 coding region) was ligated to generate the hORF-A(Wt)-rD1 and the hORF-A(Mut-ATG)-rD1, respecindicated by arrows were cloned and their sequences are shown in panel A as cD2-clone no. 1 (wt) and cD2-clone no. 2 (⌬77cD2). The positive control (pos. ctr.) clones were plasmids containing the cD2wt and spliced (⌬77cD2) cD2 coding regions. As a negative control, (neg. ctr.) water was used instead of mRNA in the PCR.
Fig. 8. Sequence and Expression of the hD2ϩ108 Transcript
A, PCR of an alternatively spliced hD2ϩ108 transcript from human thyroid. The RNA was isolated from thyroid tissue of a patient with a thyrotropin-producing pituitary adenoma (lane 1) or Graves' disease (lane 2) using the intron spanning Bp97-Bp41 oligos (sequence indicated in Table 2 ). Both the expected 491-bp amplicon and an approximately 600-bp product were generated. The sequences are shown in panel B. B, Nucleic acid and deduced amino acid sequence of the cloned thyroidal hD2ϩ108 cDNA. The 108-bp intronic sequence inserted in frame between the exon/intron junction of the hD2 coding region are bold and underlined. The inserted sequence contains an in-frame UGA (boxed). A HindIII site was used for assembling the cDNA as described in Materials and Methods. tively. The cD2-5ЈUT was produced by inserting the SacII-RI fragment of the full-length cD2 cDNA between these sites of the cD2 reporter.
The cD2-3.7⌬ was generated by cutting the intact cD2 cDNA (21) by Bsu36I and BsrGI. The ends were filled in and religated. This removed 3710 bp from the 3ЈUTR (from 1600-5310 of GenBank accession no. AF125575) between the coding region and SECIS. In the cD2-3.7exo the same length of exogenous cDNA containing no AUUUA motifs was inserted. In brief, the intact cD2 cDNA was cut by NcoI and BsrG1 (BsrGI blunted) and the NcoI-XbaI (blunt) fragment of the Pho2 gene of Neurospora crassa (kindly provided by Dr. Dorsey Stuart (Neugenesis Corp., San Carlos, CA) was ligated between these sites. The resulting construct was cut by Bsu36I-NcoI (NcoI blunted) and the Bsu36I cut of Bp107-Bp108 Vent PCR fragment (approximately 980 bp) generated from mouse TR␣-CDM13 template (50) was inserted. The constructs were confirmed by automated sequencing. Oligonucleotide sequences are indicated in Table 2 .
The ⌬77cD2 Coding Region
Total telencephalic RNA of an adult chicken was reverse transcribed and amplified using the Expand Long Template PCR System (Roche Molecular Biochemicals, Indianapolis, IN) as described earlier (21) . The fragment was ligated into pGEM-T and sequenced. The clone was completed with the missing portion of the 3ЈUTR and subcloned into D10 after the strategy used earlier for the assembling of the cD2 cDNA (21) . The mRNA isolated from the telencephalon and liver from another adult chicken was reverse transcribed using Bp11 and amplified by Taq polymerase (Sigma, St. Louis, MO) by Bp3-Bp90 primers. The bands generated on the brain cDNA were cloned into pGEM-T and sequenced. The amplifications were performed in two separate reactions.
The hD2؉108 Coding Region
The mRNA from thyroid of two patients, one with a thyrotropin-producing pituitary adenoma or Graves' disease and a normal thyroid obtained postmortem were isolated by Trizol (Life Technologies, Inc.). Reverse transcription was started by Bp112 and amplified by the intron spanning Bp97-Bp41 primers using the GIBCO Supermix. The approximately 600-bp long upper band was cloned from all three samples. They were identical by sequencing. A D2ϩ108 PCR fragment obtained by Bp113-111 was also cloned from the Graves' sample, ligated into pGEM-T (Promega Corp.) (5Ј at T7). A SacII-HindIII fragment (the latter from the insert) was placed between these sites of the Bp97-Bp41 insert producing the hD2ϩ108 coding in pGEM-T (hD2ϩ108pGEM-T). To place the insert 5Ј to a SECIS element in the D10 vector the SphIPstI fragment of the hD2ϩ108pGEM-T was inserted between these sites of hD2-D10-SelP or N-FLAGhD2-D10-SelP producing D2ϩ108-SelP and FLAG D2ϩ108-SelP, respectively. The constructs were sequenced in the ABI Prism 377 automated sequencer using dye terminators.
Deiodinase Assays
Homogenates of transfected cells were assayed in duplicate for either D2 or D1 activity as described (21) . In brief, D2 assays contained [
125 I]T 4 , 2 nM T 4 , and 20 mM dithiothreitol (DTT) in phosphate-EDTA (PE) buffer while for D1 measurements [
125 I]rT 3 , 1 M rT 3 and 10 mM DTT was used in a 300-l volume. Activity was expressed as pmol/min⅐mg protein. A telencephalon sample from an adult chicken was homogenized in PE buffer containing 0.25 sucrose and 10 mM DTT. The sample was taken from the same animal used earlier for liver D2 measurements (21) . For the maximum velocity and Michaelis-Menten constant (T 4 ) determination, 200 g protein were assayed in duplicate for 5Ј-deiodinase activity in a final volume of 300 l PE buffer containing 20 mM DTT, [ 125 I]T 4 , 1, 1.5, 3, and 10 nM T 4 and 1 mM 6-n-propylthiouracil. Incubation was for 120 min at 37 C. Activity was expressed as fmol T 4 deiodinated/h⅐mg protein.
Northern Blots
D10 based constructs were transfected into HEK-293 cells as described. On the second day after transfection, 1 g/ml tetracycline was added to the culture medium to block transcription (47) . Cells were harvested after 13 h after tetracycline addition and RNA was isolated using Trizol LS (Life Technologies, Inc.). RNA was treated using ribonuclease-free deoxyribonuclease I (Life Technologies, Inc.), following the instructions of the manufacturer. Ten micrograms of total RNA were processed for Northern blot. The experiment was performed on two separate samples for each construct. The blot was probed with a 450-bp cD2 coding region probe (21) then stripped and probed with a 330-bp probe generated by PCR (Bp135-Bp136) containing the SECIS region of cD2. The blot was exposed for 20 h at Ϫ80 C on Biomax film (Eastman Kodak, Rochester, NY). Northern blots were performed as described (21) . As denominator for densitometry, both the density of the 28S subunit and the amount of the hGH in the media were used to monitor loading and transfection efficiency, respectively.
Na 2 ( 75 Se)O 3 Labeling and Immunoprecipitation of Transiently Expressed FLAG-D2
The FLAG D2ϩ108-SelP or D2ϩ108-SelP constructs were transfected into HEK-293 cells. The transfected cells were cultured in the presence of 4-6 Ci of Na 2 ( 75 Se)O 3 /dish on d 2 after transfection in the presence of DMEM supplemented with 10% fetal bovine serum. Na 2 ( 75 Se)O 3 was kindly provided by the University of Missouri Research Reactor, courtesy of Drs. Marla Berry and Dolph L. Hatfield. On d 3, the cells were washed with PBS and sonicated in a lysis buffer [1% Triton X-100, 1% bovine hemoglobin, 0.2 U aprotinin/ml, 0.2 U leupeptin/ml 1 mM phenylmethylsulfonyl fluoride in Tris-saline-azide (TSA) buffer (0.01 M Tris-HCl, pH 8.0; 0.14 M NaCl)]. Sonication was followed by lysis under slow agitation at 4 C for 30 min. After centrifugation of the lysate at 4000 rpm for 15 min, each supernatant was incubated under slow agitation at 4 C for 1 h with preimmune mouse sera to a final dilution of 1:100 and 20 l Protein G Plus Protein A Agarose (Oncogene Research Products, San Diego, CA) by centrifugation at 1500 rpm for 15 min. The supernatant was incubated with 2 l of anti-FLAG M2 antibody (Sigma) and 20 l Protein G Plus Protein A Agarose (Oncogene Research Products) for 12-18 h under slow agitation at 4 C. After centrifugation at 2500 rpm for 15 min, the pellet was washed three times in 1:10 diluted lysis buffer, twice in 0.3 M TSA, and twice in 0.14 M TSA. The pellets were then heated at 95 C for 4 min in sample loading buffer, spun and resolved by SDS-PAGE. The gels were subjected to autoradiography for 12 d.
Sequences
The chicken and human 5ЈUTR are formed in the GenBank accession nos. AF125575 and AF188709 (11, 21) . The missing 5Ј portion of the mouse 5ЈUTR was recently published by Song et al. (44) (GenBank accession no. AF195885). The rat D2 5ЈUTR is contained in the GenBank entry nos. U53505 and AF249274 (1, 12) . The TSS of the chicken and mouse D2 mRNA was determined by 5ЈRACE and of the human by 5ЈRACE, S1 digestion and primer extension (11, 21, 44) . The putative TSS of rat D2 was assigned by sequence alignment. The sequence of the ⌬77cD2 coding region was deposited into the GenBank under accession no. AF401753.
